UC96:LSE:LSE-UBS (Irl) ETF plc - Factor MSCI USA Prime Value UCITS ETF (USD) A-dis (GBX)

ETF | Others |

Last Closing

USD 2762.5

Change

-9.00 (-0.32)%

Market Cap

USD 0.32B

Volume

2.84K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-23 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

N/A

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 592.18B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 592.18B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

N/A

USD 331.07B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing UC96:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.83% 57% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.83% 56% F 57% F
Trailing 12 Months  
Capital Gain 19.37% 71% C- 70% C-
Dividend Return 0.00% 1% F 2% F
Total Return 19.37% 70% C- 70% C-
Trailing 5 Years  
Capital Gain 67.37% 77% C+ 80% B-
Dividend Return 0.02% 11% F 6% D-
Total Return 67.40% 74% C 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 10.12% 72% C 73% C
Dividend Return 10.12% 71% C- 72% C
Total Return 0.00% 13% F 10% F
Risk Return Profile  
Volatility (Standard Deviation) 10.69% 65% D 78% C+
Risk Adjusted Return 94.68% 97% N/A 98% N/A
Market Capitalization 0.32B 62% D 54% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.